Trial Profile
A Retrospective Study Investigating Maintenance Therapy with Dasatinib in Patients with Chronic Myeloid Leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2018
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 27 Jul 2018 New trial record
- 17 Jun 2018 Results of a retrospective study assessing maintenance therapy with dasatinib every other day in CP-CML patients along with the results of a prospective maintenance study which is a part of OPTIM dasatinib trial, presented at the 23rd Congress of the European Haematology Association.